$COHN
Cohen & Co Inc. Stock $cohn

$cohn Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-K Financial Statement

#000143774921005149 Filed on March 05, 2021

Income Statement

Concept	2020 Q4	2019 Q4	2019 Q3
Revenue	$66.37M	$16.09M	$11.27M
YoY Change	312.46%	3.0%	-7.93%
Cost Of Revenue	$1.838M	$1.942M	$1.440M
YoY Change	-5.36%	-49.62%	-2.9%
Gross Profit	$64.53M	$14.15M	$9.827M
YoY Change	356.09%	20.24%	-8.62%
Gross Profit Margin	97.23%	87.93%	87.22%
Selling, General & Admin	$26.67M	$10.04M	$10.19M
YoY Change	165.74%	6.83%	-1.4%
% of Gross Profit	41.33%	70.93%	103.69%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$85.00K	$79.00K	$80.00K
YoY Change	7.59%	-7.06%	5.26%
% of Gross Profit	0.13%	0.56%	0.81%
Operating Expenses	$26.75M	$10.11M	$10.27M
YoY Change	164.5%	6.71%	-1.23%
Operating Profit	$37.78M	$4.034M	-$443.0K
YoY Change	836.42%	76.31%	-224.44%
Interest Expense	-$2.195M	-$2.443M	$46.65M
YoY Change	-10.15%	-207.06%	2035.01%
% of Operating Profit	-5.81%	-60.56%
Other Income/Expense, Net
YoY Change
Pretax Income	$35.58M	$1.591M	-$2.088M
YoY Change	2136.33%	26416.67%	14.16%
Income Tax	-$8.046M	$394.0K	-$170.0K
% Of Pretax Income	-22.61%	24.76%
Net Earnings	$14.75M	$774.0K	-$1.216M
YoY Change	1805.81%	-285.17%	86.79%
Net Earnings / Revenue	22.23%	4.81%	-10.79%
Basic Earnings Per Share	$13.78	$0.69	-$1.06
Diluted Earnings Per Share	$7.64	$0.56	-$1.06
COMMON SHARES
Basic Shares Outstanding	1.070M	1.125M	1.144M
Diluted Shares Outstanding	5.207M	2.757M	1.676M

Balance Sheet

Concept	2020 Q4	2019 Q4	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$42.00M	$8.304M	$14.13M
YoY Change	405.73%	-41.13%	173.52%
Cash & Equivalents	$42.00M	$8.304M	$14.13M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables	$55.73M	$96.60M	$99.60M
Other Receivables	$3.929M	$46.63M	$5.949M
Total Short-Term Assets	$101.7M	$151.5M	$119.7M
YoY Change	-32.91%	-3.35%	25.29%
LONG-TERM ASSETS
Property, Plant & Equipment	$799.0K	$916.0K	$7.460M
YoY Change	-12.77%	-19.15%
Goodwill	$109.0K	$7.992M	$7.992M
YoY Change	-98.64%	0.0%	0.0%
Intangibles	$166.0K	$166.0K	$166.0K
YoY Change	0.0%	0.0%	0.0%
Long-Term Investments	$13.48M	$3.799M	$3.410M
YoY Change	254.88%		-98.63%
Other Assets	$7.397M
YoY Change
Total Long-Term Assets	$6.048B	$7.850B	$7.328B
YoY Change	-22.96%	-1.37%	55.09%
TOTAL ASSETS
Total Short-Term Assets	$101.7M	$151.5M	$119.7M
Total Long-Term Assets	$6.048B	$7.850B	$7.328B
Total Assets	$6.149B	$8.002B	$7.447B
YoY Change	-23.15%	-1.4%	54.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$202.9M	$261.6M	$140.7M
YoY Change	-22.41%	22.77%	14.17%
Accrued Expenses	$20.89M	$11.74M	$11.68M
YoY Change	77.95%	123.43%	170.82%
Deferred Revenue
YoY Change
Short-Term Debt	$5.713B	$7.534B	$7.100B
YoY Change	-24.17%	-1.79%	57.54%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$5.937B	$7.808B	$7.252B
YoY Change	-23.96%	-1.04%	56.49%
LONG-TERM LIABILITIES
Long-Term Debt	$59.06M	$65.84M	$64.63M
YoY Change	-10.31%	7.97%	7.53%
Other Long-Term Liabilities	$51.85M	$77.95M	$90.02M
YoY Change	-33.48%	-35.11%	10.83%
Total Long-Term Liabilities	$110.9M	$143.8M	$154.6M
YoY Change	-22.87%	-20.6%	9.43%
TOTAL LIABILITIES
Total Short-Term Liabilities	$5.937B	$7.808B	$7.252B
Total Long-Term Liabilities	$110.9M	$143.8M	$154.6M
Total Liabilities	$6.048B	$7.953B	$7.408B
YoY Change	-23.95%	-1.49%	55.07%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.34M	-$34.52M	-$35.29M
YoY Change	-41.07%	8.12%	12.81%
Common Stock	$13.00K	$12.00K	$12.00K
YoY Change	8.33%	0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$43.91M	$33.32M	$32.66M
YoY Change
Total Liabilities & Shareholders Equity	$6.149B	$8.002B	$7.447B
YoY Change	-23.15%	-1.4%	54.5%

Cashflow Statement

Concept	2020 Q4	2019 Q4	2019 Q3
OPERATING ACTIVITIES
Net Income	$14.75M	$774.0K	-$1.216M
YoY Change	1805.81%	-285.17%	86.79%
Depreciation, Depletion And Amortization	$85.00K	$79.00K	$80.00K
YoY Change	7.59%	-7.06%	5.26%
Cash From Operating Activities	-$73.85M	-$6.311M	-$539.0K
YoY Change	1070.23%	-1.39%	-95.82%
INVESTING ACTIVITIES
Capital Expenditures	-$71.00K	-$7.000K	-$66.00K
YoY Change	914.29%	-98.35%	-76.34%
Acquisitions
YoY Change
Other Investing Activities	-$1.130M	-$513.0K	$820.0K
YoY Change	120.27%	-103.23%	-78.92%
Cash From Investing Activities	-$1.201M	-$520.0K	$754.0K
YoY Change	130.96%	-103.37%	-79.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-12.48M	884.0K	949.0K
YoY Change	-1511.88%	88300.0%	-144.7%
NET CHANGE
Cash From Operating Activities	-73.85M	-6.311M	-539.0K
Cash From Investing Activities	-1.201M	-520.0K	754.0K
Cash From Financing Activities	-12.48M	884.0K	949.0K
Net Change In Cash	-87.54M	-5.947M	1.164M
YoY Change	1371.92%	-165.74%	-110.2%
FREE CASH FLOW
Cash From Operating Activities	-$73.85M	-$6.311M	-$539.0K
Capital Expenditures	-$71.00K	-$7.000K	-$66.00K
Free Cash Flow	-$73.78M	-$6.304M	-$473.0K
YoY Change	1070.4%	5.47%	-96.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020	cohn	Accretion Of Income On Other Investments AccretionOfIncomeOnOtherInvestments	-124000
CY2019	cohn	Accretion Of Income On Other Investments AccretionOfIncomeOnOtherInvestments	-424000
CY2018	cohn	Accretion Of Income On Other Investments AccretionOfIncomeOnOtherInvestments	-1423000
CY2020	cohn	Acquisition Surrender Of Additional Units Of Consolidated Subsidiary Net AcquisitionSurrenderOfAdditionalUnitsOfConsolidatedSubsidiaryNet	1765000
CY2019	cohn	Acquisition Surrender Of Additional Units Of Consolidated Subsidiary Net AcquisitionSurrenderOfAdditionalUnitsOfConsolidatedSubsidiaryNet	-28000
CY2018	cohn	Acquisition Surrender Of Additional Units Of Consolidated Subsidiary Net AcquisitionSurrenderOfAdditionalUnitsOfConsolidatedSubsidiaryNet	217000
CY2019	cohn	Additional Units Purchased AdditionalUnitsPurchased
CY2020	cohn	Additional Units Purchased AdditionalUnitsPurchased	275000
CY2019Q2	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	895000
CY2019Q1	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	811000
CY2020	cohn	Changesfrom Net Income Attributable To Parent And Transfers To From Noncontrolling Interest ChangesfromNetIncomeAttributableToParentAndTransfersToFromNoncontrollingInterest	12440000
CY2018	cohn	Interest Income From Repurchase Agreements InterestIncomeFromRepurchaseAgreements	67846000
CY2020Q4	cohn	Asset Managements Fees Receivable AssetManagementsFeesReceivable	879000
CY2019Q4	cohn	Asset Managements Fees Receivable AssetManagementsFeesReceivable	1159000
CY2020	cohn	Business Development Occupancy And Equipment Expense BusinessDevelopmentOccupancyAndEquipmentExpense	2708000
CY2019	cohn	Business Development Occupancy And Equipment Expense BusinessDevelopmentOccupancyAndEquipmentExpense	3402000
CY2018	cohn	Business Development Occupancy And Equipment Expense BusinessDevelopmentOccupancyAndEquipmentExpense	2995000
CY2020Q4	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	671000
CY2020Q3	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	641000
CY2020Q2	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	640000
CY2020Q1	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	756000
CY2019Q4	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	926000
CY2019Q3	cohn	Business Development Occupancy Equipment BusinessDevelopmentOccupancyEquipment	770000
CY2019	cohn	Changesfrom Net Income Attributable To Parent And Transfers To From Noncontrolling Interest ChangesfromNetIncomeAttributableToParentAndTransfersToFromNoncontrollingInterest	-2026000
CY2018	cohn	Changesfrom Net Income Attributable To Parent And Transfers To From Noncontrolling Interest ChangesfromNetIncomeAttributableToParentAndTransfersToFromNoncontrollingInterest	-2680000
CY2020Q4	cohn	Common Stock Shares Unvested Or Restricted Awards CommonStockSharesUnvestedOrRestrictedAwards	286566
CY2019Q4	cohn	Common Stock Shares Unvested Or Restricted Awards CommonStockSharesUnvestedOrRestrictedAwards	73715
CY2020Q4	cohn	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	41172000
CY2019Q4	cohn	Deferred Tax Assets Liabilities Gross DeferredTaxAssetsLiabilitiesGross	92779000
CY2020Q4	cohn	Deferred Tax Liabilities Unrealized Gain On Debt DeferredTaxLiabilitiesUnrealizedGainOnDebt	5670000
CY2019Q4	cohn	Deferred Tax Liabilities Unrealized Gain On Debt DeferredTaxLiabilitiesUnrealizedGainOnDebt	7911000
CY2020	cohn	Earnings Per Share Adjustment EarningsPerShareAdjustment	9452000
CY2019	cohn	Earnings Per Share Adjustment EarningsPerShareAdjustment	246000
CY2018	cohn	Earnings Per Share Adjustment EarningsPerShareAdjustment	390000
CY2020	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfIncome	124000
CY2019	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Accretion Of Income FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetAccretionOfIncome	414000
CY2020	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Trading FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetTrading	-57000
CY2019	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Net Trading FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetNetTrading
CY2020	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reclassification Of Rtls FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReclassificationOfRtls	5278000
CY2019	cohn	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Reclassification Of Rtls FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetReclassificationOfRtls
CY2020Q4	cohn	Interest Payable Securities Sold Not Yet Purchased InterestPayableSecuritiesSoldNotYetPurchased	435000
CY2019Q4	cohn	Interest Payable Securities Sold Not Yet Purchased InterestPayableSecuritiesSoldNotYetPurchased	914000
CY2019	cohn	Issuance Of Units For Purchase IssuanceOfUnitsForPurchase	22429541
CY2020	cohn	Income Tax Expense Benefit Impact IncomeTaxExpenseBenefitImpact	-2945000
CY2019	cohn	Income Tax Expense Benefit Impact IncomeTaxExpenseBenefitImpact	319000
CY2018	cohn	Income Tax Expense Benefit Impact IncomeTaxExpenseBenefitImpact	394000
CY2019Q4	cohn	Increase Decrease In Other Investments IncreaseDecreaseInOtherInvestments	7779000
CY2020	cohn	Increase Decrease In Other Investments IncreaseDecreaseInOtherInvestments	-9694000
CY2020	cohn	Incremental Common Shares Attributable To Restricted Units Or Shares IncrementalCommonSharesAttributableToRestrictedUnitsOrShares	124922
CY2019	cohn	Incremental Common Shares Attributable To Restricted Units Or Shares IncrementalCommonSharesAttributableToRestrictedUnitsOrShares
CY2018	cohn	Incremental Common Shares Attributable To Restricted Units Or Shares IncrementalCommonSharesAttributableToRestrictedUnitsOrShares
CY2020	cohn	Interest Income Expense Including Unrealized Gains And Losses InterestIncomeExpenseIncludingUnrealizedGainsAndLosses	73611000
CY2019	cohn	Interest Income Expense Including Unrealized Gains And Losses InterestIncomeExpenseIncludingUnrealizedGainsAndLosses	38172000
CY2018	cohn	Interest Income Expense Including Unrealized Gains And Losses InterestIncomeExpenseIncludingUnrealizedGainsAndLosses	29298000
CY2020	cohn	Interest Income Expense Related Party InterestIncomeExpenseRelatedParty	5462000
CY2019	cohn	Interest Income Expense Related Party InterestIncomeExpenseRelatedParty	3952000
CY2018	cohn	Interest Income Expense Related Party InterestIncomeExpenseRelatedParty	4645000
CY2020	cohn	Interest Income From Repurchase Agreements InterestIncomeFromRepurchaseAgreements	98710000
CY2019	cohn	Interest Income From Repurchase Agreements InterestIncomeFromRepurchaseAgreements	176336000
CY2019Q4	cohn	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust Net Of Ownership Interest In Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrustNetOfOwnershipInterestInTrust	49614000
CY2019	cohn	Minority Interest Increase Decrease Net MinorityInterestIncreaseDecreaseNet	2550000
CY2020	cohn	Minority Interest Increase Decrease Net MinorityInterestIncreaseDecreaseNet	13489000
CY2018	cohn	Minority Interest Increase Decrease Related To Units Of Consolidated Subsidiary MinorityInterestIncreaseDecreaseRelatedToUnitsOfConsolidatedSubsidiary
CY2019	cohn	Minority Interest Increase Decrease Related To Units Of Consolidated Subsidiary MinorityInterestIncreaseDecreaseRelatedToUnitsOfConsolidatedSubsidiary	-23000
CY2020	cohn	Minority Interest Increase Decrease Related To Units Of Consolidated Subsidiary MinorityInterestIncreaseDecreaseRelatedToUnitsOfConsolidatedSubsidiary
CY2020Q4	cohn	Noncontrolling Interest Decrease From Distributions And Dividends To Noncontrolling Interest Holders NoncontrollingInterestDecreaseFromDistributionsAndDividendsToNoncontrollingInterestHolders	9729000
CY2018	cohn	Noncontrolling Interest Increase Decrease From Business Combination Deconsolidation NoncontrollingInterestIncreaseDecreaseFromBusinessCombinationDeconsolidation	195000
CY2019	cohn	Noncontrolling Interest Increase Decrease From Business Combination Deconsolidation NoncontrollingInterestIncreaseDecreaseFromBusinessCombinationDeconsolidation	-47000
CY2020	cohn	Noncontrolling Interest Increase Decrease From Business Combination Deconsolidation NoncontrollingInterestIncreaseDecreaseFromBusinessCombinationDeconsolidation	1706000
CY2018	cohn	Noncontrolling Interest Increase From Equitybased Compensation NoncontrollingInterestIncreaseFromEquitybasedCompensation	197000
CY2019	cohn	Noncontrolling Interest Increase From Equitybased Compensation NoncontrollingInterestIncreaseFromEquitybasedCompensation	263000
CY2020	cohn	Noncontrolling Interest Increase From Equitybased Compensation NoncontrollingInterestIncreaseFromEquitybasedCompensation	12313000
CY2019	cohn	Noncontrolling Interest Increase From Investment NoncontrollingInterestIncreaseFromInvestment	10329000
CY2020	cohn	Noncontrolling Interest Increase From Investment NoncontrollingInterestIncreaseFromInvestment	13489000
CY2020	cohn	Noncontrolling Interest Net Share Settlement NoncontrollingInterestNetShareSettlement	39000
CY2018	cohn	Noncontrolling Interest Reclass Of Net Share Settlement NoncontrollingInterestReclassOfNetShareSettlement	24000
CY2019	cohn	Noncontrolling Interest Reclass Of Net Share Settlement NoncontrollingInterestReclassOfNetShareSettlement	41000
CY2020Q4	cohn	Number Of Counterparties Related To Reverse Repurchase Agreements NumberOfCounterpartiesRelatedToReverseRepurchaseAgreements	38
CY2019Q4	cohn	Number Of Counterparties Related To Reverse Repurchase Agreements NumberOfCounterpartiesRelatedToReverseRepurchaseAgreements	41
CY2020	cohn	Operating Expense Income Related Party Transactions OperatingExpenseIncomeRelatedPartyTransactions	1150000
CY2019	cohn	Operating Expense Income Related Party Transactions OperatingExpenseIncomeRelatedPartyTransactions	428000
CY2018	cohn	Operating Expense Income Related Party Transactions OperatingExpenseIncomeRelatedPartyTransactions	491000
CY2018	cohn	Other Comprehensive Income Acquisition Surrender Of Additional Units OtherComprehensiveIncomeAcquisitionSurrenderOfAdditionalUnits	22000
CY2019	cohn	Other Comprehensive Income Acquisition Surrender Of Additional Units OtherComprehensiveIncomeAcquisitionSurrenderOfAdditionalUnits	-4000
CY2020	cohn	Other Comprehensive Income Acquisition Surrender Of Additional Units OtherComprehensiveIncomeAcquisitionSurrenderOfAdditionalUnits	59000
CY2020Q4	cohn	Other Instruments Sold Not Yet Purchased At Fair Value OtherInstrumentsSoldNotYetPurchasedAtFairValue	7561000
CY2020Q4	cohn	Other Investment Sold Not Yet Purchased OtherInvestmentSoldNotYetPurchased	7415000
CY2019Q4	cohn	Other Investment Sold Not Yet Purchased OtherInvestmentSoldNotYetPurchased
CY2020Q4	cohn	Other Investment Sold Not Yet Purchased Unrealized Gain Loss OtherInvestmentSoldNotYetPurchasedUnrealizedGainLoss	146000
CY2020Q4	cohn	Other Investments Accumulated Unrealized Gain Loss OtherInvestmentsAccumulatedUnrealizedGainLoss	36662000
CY2019Q4	cohn	Other Investments Accumulated Unrealized Gain Loss OtherInvestmentsAccumulatedUnrealizedGainLoss	549000
CY2020Q4	cohn	Other Investments Fair Value Disclosure OtherInvestmentsFairValueDisclosure	58540000
CY2019Q4	cohn	Other Investments Fair Value Disclosure OtherInvestmentsFairValueDisclosure	14864000
CY2020Q4	cohn	Other Miscellaneous Receivables OtherMiscellaneousReceivables	425000
CY2019Q4	cohn	Other Miscellaneous Receivables OtherMiscellaneousReceivables	595000
CY2020	cohn	Payments To Acquire Equity Method Investments Including Noncash Transfer PaymentsToAcquireEquityMethodInvestmentsIncludingNoncashTransfer	12722000
CY2020	cohn	Payments To Acquire Other Investments Sold Not Yet Purchased PaymentsToAcquireOtherInvestmentsSoldNotYetPurchased	12519000
CY2019	cohn	Payments To Acquire Other Investments Sold Not Yet Purchased PaymentsToAcquireOtherInvestmentsSoldNotYetPurchased
CY2018	cohn	Payments To Acquire Other Investments Sold Not Yet Purchased PaymentsToAcquireOtherInvestmentsSoldNotYetPurchased
CY2020	cohn	Principal Transactions And Other Income PrincipalTransactionsAndOtherIncome	45506000
CY2019	cohn	Principal Transactions And Other Income PrincipalTransactionsAndOtherIncome	2103000
CY2018	cohn	Principal Transactions And Other Income PrincipalTransactionsAndOtherIncome	4573000
CY2020	cohn	Principal Transactions And Other Income Related Party PrincipalTransactionsAndOtherIncomeRelatedParty	770000
CY2019	cohn	Principal Transactions And Other Income Related Party PrincipalTransactionsAndOtherIncomeRelatedParty	564000
CY2018	cohn	Principal Transactions And Other Income Related Party PrincipalTransactionsAndOtherIncomeRelatedParty	744000
CY2020	cohn	Proceeds From Nonconvertible Debt ProceedsFromNonconvertibleDebt	4500000
CY2019	cohn	Proceeds From Nonconvertible Debt ProceedsFromNonconvertibleDebt
CY2018	cohn	Proceeds From Nonconvertible Debt ProceedsFromNonconvertibleDebt
CY2020	cohn	Proceeds From Payments For Redeemable Financial Instruments ProceedsFromPaymentsForRedeemableFinancialInstruments
CY2019	cohn	Proceeds From Payments For Redeemable Financial Instruments ProceedsFromPaymentsForRedeemableFinancialInstruments	1268000
CY2018	cohn	Proceeds From Payments For Redeemable Financial Instruments ProceedsFromPaymentsForRedeemableFinancialInstruments	500000
CY2020	cohn	Proceeds From Sale And Maturity Of Other Investments Not Yet Purchased ProceedsFromSaleAndMaturityOfOtherInvestmentsNotYetPurchased	20997000
CY2019	cohn	Proceeds From Sale And Maturity Of Other Investments Not Yet Purchased ProceedsFromSaleAndMaturityOfOtherInvestmentsNotYetPurchased
CY2018	cohn	Proceeds From Sale And Maturity Of Other Investments Not Yet Purchased ProceedsFromSaleAndMaturityOfOtherInvestmentsNotYetPurchased
CY2020	cohn	Ratio Of Shares To Vote RatioOfSharesToVote	10
CY2020	cohn	Realized Gain Loss On Other Investments RealizedGainLossOnOtherInvestments	7300000
CY2019	cohn	Realized Gain Loss On Other Investments RealizedGainLossOnOtherInvestments	-1033000
CY2018	cohn	Realized Gain Loss On Other Investments RealizedGainLossOnOtherInvestments	490000
CY2020	cohn	Realized Gain Loss On Other Investments Sold Not Yet Purchased RealizedGainLossOnOtherInvestmentsSoldNotYetPurchased	917000
CY2019	cohn	Realized Gain Loss On Other Investments Sold Not Yet Purchased RealizedGainLossOnOtherInvestmentsSoldNotYetPurchased
CY2018	cohn	Realized Gain Loss On Other Investments Sold Not Yet Purchased RealizedGainLossOnOtherInvestmentsSoldNotYetPurchased
CY2020Q4	cohn	Receivables From Unsettled Regular Way Trades Net ReceivablesFromUnsettledRegularWayTradesNet	2961000
CY2019Q4	cohn	Receivables From Unsettled Regular Way Trades Net ReceivablesFromUnsettledRegularWayTradesNet	12170000
CY2020Q4	cohn	Redeemable Financial Instruments RedeemableFinancialInstruments	11957000
CY2019Q4	cohn	Redeemable Financial Instruments RedeemableFinancialInstruments	16983000
CY2020	cohn	Redeemable Noncontrolling Interest Membership Units Not Held Share Ratio RedeemableNoncontrollingInterestMembershipUnitsNotHeldShareRatio	10
CY2020	cohn	Redemption Of Redeemable Financial Instrument RedemptionOfRedeemableFinancialInstrument	4921000
CY2019	cohn	Redemption Of Redeemable Financial Instrument RedemptionOfRedeemableFinancialInstrument	1500000
CY2018	cohn	Redemption Of Redeemable Financial Instrument RedemptionOfRedeemableFinancialInstrument
CY2012Q1	cohn	Revenue Share Arrangement Percentage Of Revenues Received RevenueShareArrangementPercentageOfRevenuesReceived	0.08
CY2020	cohn	Unrealized Gain Loss On Investments Sold Not Yet Purchased UnrealizedGainLossOnInvestmentsSoldNotYetPurchased	146000
CY2020Q4	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2517000
CY2020Q3	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2242000
CY2020Q2	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2548000
CY2020Q1	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2580000
CY2019Q4	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2950000
CY2019Q3	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2403000
CY2019Q2	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2056000
CY2019Q1	cohn	Subscriptions Clearing And Execution SubscriptionsClearingAndExecution	2273000
CY2020	cohn	Subscriptions Clearing And Execution Expense SubscriptionsClearingAndExecutionExpense	9887000
CY2019	cohn	Subscriptions Clearing And Execution Expense SubscriptionsClearingAndExecutionExpense	9682000
CY2018	cohn	Subscriptions Clearing And Execution Expense SubscriptionsClearingAndExecutionExpense	8627000
CY2020Q4	cohn	Trading Receivable TradingReceivable	225000
CY2019Q4	cohn	Trading Receivable TradingReceivable	41172000
CY2019	cohn	Unrealized Gain Loss On Investments Sold Not Yet Purchased UnrealizedGainLossOnInvestmentsSoldNotYetPurchased
CY2018	cohn	Unrealized Gain Loss On Investments Sold Not Yet Purchased UnrealizedGainLossOnInvestmentsSoldNotYetPurchased
CY2020	cohn	Unrestricted Units Exchangeable Into Shares UnrestrictedUnitsExchangeableIntoShares	2800597
CY2019	cohn	Unrestricted Units Exchangeable Into Shares UnrestrictedUnitsExchangeableIntoShares	544599
CY2018	cohn	Unrestricted Units Exchangeable Into Shares UnrestrictedUnitsExchangeableIntoShares	532409
CY2020	dei	Amendment Flag AmendmentFlag	false
CY2020	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2020	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2020	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
CY2020	dei	Document Period End Date DocumentPeriodEndDate	2020-12-31
CY2020	dei	Document Type DocumentType	10-K
CY2020	dei	Entity Central Index Key EntityCentralIndexKey	0001270436
CY2021Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1329007
CY2020	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2020	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2020	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2020	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2020Q2	dei	Entity Public Float EntityPublicFloat	7600000
CY2020	dei	Entity Registrant Name EntityRegistrantName	Cohen & Co Inc.
CY2020	dei	Entity Shell Company EntityShellCompany	false
CY2020	dei	Entity Small Business EntitySmallBusiness	true
CY2020	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2020	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2020	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2020	dei	Trading Symbol TradingSymbol	cohn
CY2020Q4	srt	Excess Net Capital At1500 Percent ExcessNetCapitalAt1500Percent	67869000
CY2019Q4	srt	Excess Net Capital At1500 Percent ExcessNetCapitalAt1500Percent	59915000
CY2020Q4	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	957000
CY2019Q4	srt	Minimum Net Capital Required1 MinimumNetCapitalRequired1	1695000
CY2020Q4	srt	Net Capital NetCapital	68826000
CY2019Q4	srt	Net Capital NetCapital	61610000
CY2020Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	156678000
CY2019Q4	srt	Payables To Broker Dealers And Clearing Organizations PayablesToBrokerDealersAndClearingOrganizations	241261000
CY2018	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	820000
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	626000
CY2019	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	509000
CY2018	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	552000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1468218
CY2018	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1413155
CY2020Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	46251000
CY2019Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	20295000
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	46251000
CY2019Q4	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	20295000
CY2020Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	162000
CY2019Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	362000
CY2020Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	125000
CY2019Q4	us-gaap	Accrued Fees And Other Revenue Receivable AccruedFeesAndOtherRevenueReceivable	150000
CY2020Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes	99000
CY2019Q4	us-gaap	Accrued Income Taxes AccruedIncomeTaxes
CY2020Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	2275000
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	736000
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	548000
CY2019Q4	us-gaap	Accrued Investment Income Receivable AccruedInvestmentIncomeReceivable	3549000
CY2020Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	1048000
CY2019Q4	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	729000
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	1320000
CY2019Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Excluding Capital Leased Assets AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipmentExcludingCapitalLeasedAssets	981000
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-850000
CY2018Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-908000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-915000
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-821000
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	65031000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	68714000
CY2018	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	75000
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	128000
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	54000
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12553000
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	744000
CY2018	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	623000
CY2020Q4	us-gaap	Alternative Investment AlternativeInvestment	2548
CY2019Q4	us-gaap	Alternative Investment AlternativeInvestment	2891000
CY2020Q4	us-gaap	Assets Assets	6149379000
CY2019Q4	us-gaap	Assets Assets	8001624000
CY2020Q4	us-gaap	Assets Under Management Carrying Amount AssetsUnderManagementCarryingAmount	2770000000
CY2020Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	5323000
CY2020	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">2.</div> BASIS OF PRESENTATION </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:27pt;">The accounting and reporting policies of the Company conform to U.S. GAAP.  Certain prior period amounts have been reclassified to conform to the current period presentation. </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> Effective <div style="display: inline; font-style: italic; font: inherit;"> June 1, 2019, </div>the Company changed its accounting policy regarding the netting of reverse repo and repo transactions and updated prior periods' balances to be consistent with this new accounting policy.  This change resulted in an increase in the repo and reverse repo amounts included in the consolidated balance sheet as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2018 </div>of <div style="display: inline; font-style: italic; font: inherit;">$2,461,177.</div>  See note <div style="display: inline; font-style: italic; font: inherit;">11.</div> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div></div>
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	41996000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8304000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8304000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14106000
CY2017Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	22933000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	41996000
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	33692000
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-5802000
CY2018	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-8827000
CY2020Q4	us-gaap	Collateralized Financings CollateralizedFinancings	41119000
CY2019Q4	us-gaap	Collateralized Financings CollateralizedFinancings	9524000
CY2018Q4	us-gaap	Collateralized Financings CollateralizedFinancings	4277000
CY2017Q4	us-gaap	Collateralized Financings CollateralizedFinancings	1219000
CY2020Q4	us-gaap	Commissions Payable To Broker Dealers And Clearing Organizations CommissionsPayableToBrokerDealersAndClearingOrganizations
CY2019Q4	us-gaap	Commissions Payable To Broker Dealers And Clearing Organizations CommissionsPayableToBrokerDealersAndClearingOrganizations	32820000
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared
CY2019	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.40
CY2018	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.80
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1325529
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	1193624
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1325529
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	1193624
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	13000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	12000
CY2017Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	16934944
CY2018Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	16431254
CY2019Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	38952715
CY2020Q4	us-gaap	Common Unit Outstanding CommonUnitOutstanding	38418255
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14240000
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2057000
CY2018	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2543000
CY2020	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	24351000
CY2019	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1518000
CY2018	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-1562000
CY2020Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	28875000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	1688000
CY2020Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2368000
CY2020Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-8683000
CY2019Q4	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	423000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-702000
CY2019Q2	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-618000
CY2019Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-622000
CY2020	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	38591000
CY2019	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3575000
CY2018	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-4105000
CY2020	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12.2pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12.2pt;"><div style="display: inline; font-style: italic;">V. Business Concentration </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:12.2pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-12.2pt;"><div style="display: inline; font-style: italic;"></div> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">A substantial portion of the Company's asset management revenues in a year <div style="display: inline; font-style: italic; font: inherit;"> may </div>be derived from a small number of transactions. For the year ended <div style="display: inline;"><div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020</div></div>, the Company earned asset management revenue of <div style="display: inline; font-style: italic; font: inherit;">$3,407</div> from CDOs and <div style="display: inline; font-style: italic; font: inherit;">$5,352</div> from other investment funds. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Other than revenue earned in its matched book repo operations, the Company's trading revenue is generated from transactions with a diverse set of institutional customers.  The Company does <div style="display: inline; font-style: italic; font: inherit;">not</div> consider its trading revenue, other than revenue earned in its matched book repo operations, to be concentrated from a customer or counterparty perspective. See note <div style="display: inline; font-style: italic; font: inherit;">11</div> for discussion of concentrations within its matched book repo operations.</div></div></div></div></div></div></div>
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	87782000
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	45625000
CY2018	us-gaap	Costs And Expenses CostsAndExpenses	45727000
CY2020Q4	us-gaap	Costs And Expenses CostsAndExpenses	28590000
CY2020Q3	us-gaap	Costs And Expenses CostsAndExpenses	15784000
CY2020Q2	us-gaap	Costs And Expenses CostsAndExpenses	16193000
CY2020Q1	us-gaap	Costs And Expenses CostsAndExpenses	27215000
CY2019Q4	us-gaap	Costs And Expenses CostsAndExpenses	12056000
CY2019Q3	us-gaap	Costs And Expenses CostsAndExpenses	11710000
CY2019Q2	us-gaap	Costs And Expenses CostsAndExpenses	10651000
CY2019Q1	us-gaap	Costs And Expenses CostsAndExpenses	11208000
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-1000
CY2018	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-29000
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	122000
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	156000
CY2018	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	26000
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	208000
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	155000
CY2018	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-3000
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	86000
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2018	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit
CY2020Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	62496000
CY2019Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	58635000
CY2020	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	33345000
CY2019	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	22798000
CY2018	us-gaap	Debt Securities Trading Gain Loss DebtSecuritiesTradingGainLoss	22150000
CY2020	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	31269000
CY2019	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	24118000
CY2018	us-gaap	Debt Securities Trading Realized Gain Loss DebtSecuritiesTradingRealizedGainLoss	20914000
CY2020	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	2076000
CY2019	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	-1320000
CY2018	us-gaap	Debt Securities Trading Unrealized Gain Loss DebtSecuritiesTradingUnrealizedGainLoss	1236000
CY2020Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	248000
CY2019Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	301000
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-7430000
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-324000
CY2018	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-722000
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2018	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit
CY2020Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	7397000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-8877000
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-678000
CY2018	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-838000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	5670000
CY2019Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	7911000
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet
CY2019Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1339000
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1447000
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-354000
CY2018	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-116000
CY2020Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	7311000
CY2019Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	47027000
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	46842000
CY2019Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	100690000
CY2020Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	14402000
CY2019Q4	us-gaap	Deferred Tax Assets Investment In Subsidiaries DeferredTaxAssetsInvestmentInSubsidiaries	24569000
CY2020Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	13067000
CY2019Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	6572000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	20579000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	21508000
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	4238000
CY2019Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	5061000
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	312000
CY2019Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2525000
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	33775000
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	94118000
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7397000
CY2019Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	1339000
CY2020Q4	us-gaap	Deposits With Clearing Organizations And Others Securities DepositsWithClearingOrganizationsAndOthersSecurities	250000
CY2019Q4	us-gaap	Deposits With Clearing Organizations And Others Securities DepositsWithClearingOrganizationsAndOthersSecurities	250000
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	334000
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	318000
CY2018	us-gaap	Depreciation And Amortization DepreciationAndAmortization	261000
CY2020Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85000
CY2020Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	85000
CY2020Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	84000
CY2020Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	80000
CY2019Q4	us-gaap	Depreciation And Amortization DepreciationAndAmortization	79000
CY2019Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	80000
CY2019Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	78000
CY2019Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	81000
CY2020Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	1662000
CY2019Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	669000
CY2020	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	5324000
CY2019	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	6526000
CY2018	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	6200000
CY2020	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	14200000
CY2019	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-1231000
CY2018	us-gaap	Dilutive Securities Effect On Basic Earnings Per Share Other DilutiveSecuritiesEffectOnBasicEarningsPerShareOther	-1524000
CY2020	us-gaap	Dividends Dividends	27000
CY2019	us-gaap	Dividends Dividends	519000
CY2018	us-gaap	Dividends Dividends	966000
CY2018	us-gaap	Dividends Common Stock DividendsCommonStock	1392000
CY2019	us-gaap	Dividends Common Stock DividendsCommonStock	732000
CY2020	us-gaap	Dividends Common Stock DividendsCommonStock	62000
CY2020Q4	us-gaap	Due From Related Parties DueFromRelatedParties	2812000
CY2019Q4	us-gaap	Due From Related Parties DueFromRelatedParties	466000
CY2020Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	316000
CY2019Q4	us-gaap	Due To Affiliate Current And Noncurrent DueToAffiliateCurrentAndNoncurrent	403000
CY2020	us-gaap	Due To And From Broker Dealers And Clearing Organizations Disclosure DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">6.</div> RECEIVABLES FROM AND PAYABLES TO BROKERS, DEALERS, AND CLEARING AGENCIES</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:35.95pt;margin-right:0pt;margin-top:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Amounts receivable from brokers, dealers, and clearing agencies consisted of the following.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family:Tahoma;font-size:1pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:Tahoma;font-size:1pt;margin:0pt;text-align:left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td colspan="7" style="vertical-align:bottom;width:100%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">RECEIVABLES FROM BROKERS, DEALERS, AND CLEARING AGENCIES</div> </td> </tr> <tr> <td colspan="7" style="vertical-align:bottom;width:100%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Dollars in Thousands)</div> </td> </tr> </table> <div style=" margin: 0; font-family: "Times New Roman", Times, serif; font-size: 10pt"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">As of December 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;">2020</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;">2019</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; width: 70%;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Deposits with clearing organizations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">250</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Unsettled regular way trades, net</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">2,961</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">12,170</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Receivable from clearing organizations</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">49,706</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">83,712</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt 0pt 0pt 9pt; text-align: left;">Receivables from brokers, dealers, and clearing agencies</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">52,917</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">96,132</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0; font-family: "Times New Roman", Times, serif; font-size: 10pt"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> Amounts payable to brokers, dealers, and clearing agencies consisted of the following.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family:Tahoma;font-size:1pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family:Tahoma;font-size:1pt;margin:0pt;text-align:left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style=";text-indent:0;font-family:'Times New Roman', Times, serif;font-size:10pt; min-width: 700px;"> <tr> <td colspan="7" style="vertical-align:bottom;width:100%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">PAYABLES TO BROKERS, DEALERS, AND CLEARING AGENCIES</div> </td> </tr> <tr> <td colspan="7" style="vertical-align:bottom;width:100%;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">(Dollars in Thousands)</div> </td> </tr> </table> <div style=" margin: 0; font-family: "Times New Roman", Times, serif; font-size: 10pt"> </div> <div> <table border="0" cellpadding="0" cellspacing="0" style="; font-size: 10pt; font-family: "Times New Roman", Times, serif; text-indent: 0px; min-width: 700px;"> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;"><div style="display: inline; font-style: italic; font: inherit;">As of December 31,</div></div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;">2020</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;"><div style="display: inline; font-style: italic; font: inherit;">2019</div></div> </td> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Margin payable</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">156,678</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"><div style="display: inline; font-style: italic; font: inherit;">208,441</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(255, 255, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">Due to clearing agent</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">-</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">32,820</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255); vertical-align: bottom"> <td style="font-family: "Times New Roman", Times, serif; font-size: 10pt;"> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 9pt;">Payables to brokers, dealers, and clearing agencies</div> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">156,678</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt;"> </td> <td style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><div style="display: inline; font-style: italic; font: inherit;">241,261</div></td> <td nowrap="nowrap" style="width: 1%; font-family: "Times New Roman", Times, serif; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </table> </div> <div style=" margin: 0; font-family: "Times New Roman", Times, serif; font-size: 10pt"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt; background-color: rgba(0, 0, 0, 0); color: rgb(0, 0, 0);">Deposits with clearing organizations represent contractual amounts the Company is required to deposit with its clearing agents. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt; background-color: rgba(0, 0, 0, 0); color: rgb(0, 0, 0);">Securities transactions that settle in the regular way are recorded on the trade date, as if they had settled. The related amounts receivable and payable for unsettled securities transactions are recorded net in receivables from or payables to brokers, dealers, and clearing agencies on the Company's consolidated balance sheets. The related amounts receivable and payable for unsettled securities transactions are recorded net in receivables from or payables to brokers, dealers, and clearing agencies on the Company's consolidated balance sheets.</div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Receivables from clearing organizations are primarily comprised of (i) cash received by the Company upon execution of short trades that is restricted from withdrawal by the clearing agent; and (ii) cash deposited with the FICC to support the Company's General Collateral Funding (“GCF”) matched book repo business.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Margin payable represents amounts borrowed from Pershing, LLC to finance the Company's trading portfolio.  Substantially, all of the Company's investments-trading and deposits with clearing organizations serve as collateral for the margin payable.  See note <div style="display: inline; font-style: italic; font: inherit;">5</div> for interest expense incurred on margin payable. </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Due to clearing agent represents amounts due to Bank of New York under the Company's intra-day and overnight lending facility supporting the GCF matched repo business.  See note <div style="display: inline; font-style: italic; font: inherit;">11.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">    </div></div>
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	12.56
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.78
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.70
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.81
CY2018	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.14
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	13.78
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.44
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.69
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2019Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.06
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.66
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.81
CY2018	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.14
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	7.64
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.19
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.69
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.70
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2019Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.06
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	416000
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-9000
CY2018	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-262000
CY2020Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	14359000
CY2019Q4	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	4046000
CY2020Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	7360
CY2020	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P3Y36D
CY2018Q4	us-gaap	Equity Method Investments EquityMethodInvestments
CY2019Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3799000
CY2020Q4	us-gaap	Equity Method Investments EquityMethodInvestments	13482000
CY2020	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss
CY2019	us-gaap	Fair Value Assets Measured On Recurring Basis Change In Unrealized Gain Loss FairValueAssetsMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-4000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-604000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Gain Loss Included In Earnings1 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1	-123000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases	638000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Purchases FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	5601000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Sales FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales	525000
CY2020	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3	2300000
CY2019	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3 FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
CY2019Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2522000
CY2018Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2756000
CY2020Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Value FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue
CY2020Q4	us-gaap	Fair Value Of Securities Received As Collateral That Can Be Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatCanBeResoldOrRepledged	5885656000
CY2019Q4	us-gaap	Fair Value Of Securities Received As Collateral That Can Be Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatCanBeResoldOrRepledged	7769693000
CY2020Q4	us-gaap	Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged	5768018000
CY2019Q4	us-gaap	Fair Value Of Securities Received As Collateral That Have Been Resold Or Repledged FairValueOfSecuritiesReceivedAsCollateralThatHaveBeenResoldOrRepledged	7561978000
CY2020Q4	us-gaap	Financial Instruments Sold Not Yet Purchased At Fair Value FinancialInstrumentsSoldNotYetPurchasedAtFairValue	44439000
CY2019Q4	us-gaap	Financial Instruments Sold Not Yet Purchased At Fair Value FinancialInstrumentsSoldNotYetPurchasedAtFairValue	77947000
CY2020Q4	us-gaap	Goodwill Goodwill	109000
CY2019Q4	us-gaap	Goodwill Goodwill	7992000
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7883000
CY2019	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2018	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2020Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2020Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2020Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	7883000
CY2019Q4	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2019Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2019Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2019Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	30317000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-4400000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-3864000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	29784000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4096000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-4828000
CY2020Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	35580000
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2749000
CY2020Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3612000
CY2020Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12157000
CY2019Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1591000
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2088000
CY2019Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1669000
CY2019Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1930000
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-533000
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	304000
CY2018	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-964000
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-553000
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2955000
CY2018	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2020Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-244000
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1371000
CY2020Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-1233000
CY2020Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-107000
CY2019Q4	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-188000
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-109000
CY2019Q2	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-248000
CY2019Q1	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-8000
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8669000
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-523000
CY2018	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-841000
CY2020Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-8046000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-594000
CY2020Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	343000
CY2020Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-372000
CY2019Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	394000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-170000
CY2019Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-641000
CY2019Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-106000
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-10183000
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	153000
CY2018	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	17000
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	122000
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	156000
CY2018	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	25000
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	4145000
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-860000
CY2018	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1014000
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	192000
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-291000
CY2018	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-263000
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	234000
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	30000
CY2018	us-gaap	Income Taxes Paid IncomeTaxesPaid	44000
CY2020	us-gaap	Increase Decrease In Broker Dealer Related Receivables Payables Net IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet	41368000
CY2019	us-gaap	Increase Decrease In Broker Dealer Related Receivables Payables Net IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet	-73343000
CY2018	us-gaap	Increase Decrease In Broker Dealer Related Receivables Payables Net IncreaseDecreaseInBrokerDealerRelatedReceivablesPayablesNet	-44824000
CY2020	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	31595000
CY2019	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	5247000
CY2018	us-gaap	Increase Decrease In Cash Collateral For Loaned Securities IncreaseDecreaseInCashCollateralForLoanedSecurities	3058000
CY2020	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-2346000
CY2019	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	327000
CY2018	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	2000
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	10313000
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-1208000
CY2018	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	848000
CY2020	us-gaap	Increase Decrease In Financial Instruments Sold Not Yet Purchased IncreaseDecreaseInFinancialInstrumentsSoldNotYetPurchased	-33508000
CY2019	us-gaap	Increase Decrease In Financial Instruments Sold Not Yet Purchased IncreaseDecreaseInFinancialInstrumentsSoldNotYetPurchased	-42175000
CY2018	us-gaap	Increase Decrease In Financial Instruments Sold Not Yet Purchased IncreaseDecreaseInFinancialInstrumentsSoldNotYetPurchased	28235000
CY2020	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	24552000
CY2019	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	7855000
CY2018	us-gaap	Increase Decrease In Other Accounts Payable And Accrued Liabilities IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities	6334000
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-4340000
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	3768000
CY2018	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	683000
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-42696000
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	34535000
CY2018	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	8559000
CY2020	us-gaap	Increase Decrease In Payables Under Repurchase Agreements IncreaseDecreaseInPayablesUnderRepurchaseAgreements	-1821231000
CY2019	us-gaap	Increase Decrease In Payables Under Repurchase Agreements IncreaseDecreaseInPayablesUnderRepurchaseAgreements	-137321000
CY2018	us-gaap	Increase Decrease In Payables Under Repurchase Agreements IncreaseDecreaseInPayablesUnderRepurchaseAgreements	5605165000
CY2020	us-gaap	Increase Decrease In Receivables Under Repurchase Agreements IncreaseDecreaseInReceivablesUnderRepurchaseAgreements	-1783659000
CY2019	us-gaap	Increase Decrease In Receivables Under Repurchase Agreements IncreaseDecreaseInReceivablesUnderRepurchaseAgreements	-132228000
CY2018	us-gaap	Increase Decrease In Receivables Under Repurchase Agreements IncreaseDecreaseInReceivablesUnderRepurchaseAgreements	5577027000
CY2020	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	-64891000
CY2019	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	6617000
CY2018	us-gaap	Increase Decrease In Trading Securities IncreaseDecreaseInTradingSecurities	98978000
CY2020	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares	1034483
CY2019	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2018	us-gaap	Incremental Common Shares Attributable To Contingently Issuable Shares IncrementalCommonSharesAttributableToContingentlyIssuableShares
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	166000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	166000
CY2020	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	106469000
CY2019	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	183493000
CY2018	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	72886000
CY2020	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases
CY2019	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	236000
CY2018	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases
CY2020	us-gaap	Interest Expense InterestExpense	66203000
CY2019	us-gaap	Interest Expense InterestExpense	168119000
CY2018	us-gaap	Interest Expense InterestExpense	65738000
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	9589000
CY2019	us-gaap	Interest Expense Debt InterestExpenseDebt	7584000
CY2018	us-gaap	Interest Expense Debt InterestExpenseDebt	8487000
CY2020Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	1951000
CY2020Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1952000
CY2020Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	3081000
CY2020Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	2605000
CY2019Q4	us-gaap	Interest Expense Debt InterestExpenseDebt	2255000
CY2019Q3	us-gaap	Interest Expense Debt InterestExpenseDebt	1536000
CY2019Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	1939000
CY2019Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	1854000
CY2020	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	39000
CY2019	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt	100000
CY2018	us-gaap	Interest Expense Long Term Debt InterestExpenseLongTermDebt
CY2020	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	65030000
CY2019	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	164851000
CY2018	us-gaap	Interest Expense Securities Sold Under Agreements To Repurchase InterestExpenseSecuritiesSoldUnderAgreementsToRepurchase	63707000
CY2020	us-gaap	Interest Expense Short Term Borrowings Excluding Federal Funds And Securities Sold Under Agreements To Repurchase InterestExpenseShortTermBorrowingsExcludingFederalFundsAndSecuritiesSoldUnderAgreementsToRepurchase	1134000
CY2019	us-gaap	Interest Expense Short Term Borrowings Excluding Federal Funds And Securities Sold Under Agreements To Repurchase InterestExpenseShortTermBorrowingsExcludingFederalFundsAndSecuritiesSoldUnderAgreementsToRepurchase	3168000
CY2018	us-gaap	Interest Expense Short Term Borrowings Excluding Federal Funds And Securities Sold Under Agreements To Repurchase InterestExpenseShortTermBorrowingsExcludingFederalFundsAndSecuritiesSoldUnderAgreementsToRepurchase	2031000
CY2020	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	7759000
CY2019	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	6921000
CY2018	us-gaap	Interest Income Debt Securities Trading Operating InterestIncomeDebtSecuritiesTradingOperating	5040000
CY2020	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	9589000
CY2019	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	7584000
CY2018	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	8487000
CY2020	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	1162000
CY2019	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax
CY2018	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax
CY2020	us-gaap	Interest Paid Net InterestPaidNet	8711000
CY2019	us-gaap	Interest Paid Net InterestPaidNet	7265000
CY2018	us-gaap	Interest Paid Net InterestPaidNet	7145000
CY2020Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	630000
CY2019Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	711000
CY2020	us-gaap	Labor And Related Expense LaborAndRelatedExpense	59902000
CY2019	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25972000
CY2018	us-gaap	Labor And Related Expense LaborAndRelatedExpense	25385000
CY2020Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	23479000
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10965000
CY2020Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	11324000
CY2020Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	14134000
CY2019Q4	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6159000
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	7017000
CY2019Q2	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6432000
CY2019Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	6364000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8090000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	3112000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1116000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	983000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	983000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	955000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	941000
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1559000
CY2018Q4	us-gaap	Minority Interest MinorityInterest	6664000
CY2018	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-1524000
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	47100000
CY2019Q4	us-gaap	Long Term Debt LongTermDebt	48861000
CY2017Q4	us-gaap	Minority Interest MinorityInterest	8284000
CY2020Q4	us-gaap	Liabilities Liabilities	6047942000
CY2019Q4	us-gaap	Liabilities Liabilities	7952868000
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6149379000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8001624000
CY2018Q3	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	50000
CY2018Q4	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	50000
CY2019Q4	us-gaap	Minority Interest MinorityInterest	15437000
CY2020Q4	us-gaap	Minority Interest MinorityInterest	57528000
CY2018	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	426000
CY2019	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	213000
CY2020	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	9694000
CY2020	us-gaap	Nature Of Operations NatureOfOperations	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-weight: bold;"><div style="display: inline; font-style: italic; font: inherit;">1.</div> ORGANIZATION AND NATURE OF OPERATIONS </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">Organizational History</div> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Cohen Brothers, LLC (“Cohen Brothers”) was formed on <div style="display: inline; font-style: italic; font: inherit;"> October </div><div style="display: inline; font-style: italic; font: inherit;">7,</div> <div style="display: inline; font-style: italic; font: inherit;">2004</div> by Cohen Bros. Financial, LLC (“CBF”). Cohen Brothers was established to acquire the net assets of CBF's subsidiaries (the “Formation Transaction”): Cohen Bros. & Company, Inc.; Cohen Frères SAS; Dekania Investors, LLC; Emporia Capital Management, LLC; and the majority interest in Cohen Bros. & Toroian Investment Management, Inc. The Formation Transaction was accomplished through a series of transactions occurring between <div style="display: inline; font-style: italic; font: inherit;"> March </div><div style="display: inline; font-style: italic; font: inherit;">4,</div> <div style="display: inline; font-style: italic; font: inherit;">2005</div> and <div style="display: inline; font-style: italic; font: inherit;"> May </div><div style="display: inline; font-style: italic; font: inherit;">31,</div> <div style="display: inline; font-style: italic; font: inherit;">2005.</div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">From its formation until <div style="display: inline; font-style: italic; font: inherit;"> December </div><div style="display: inline; font-style: italic; font: inherit;">16,</div> <div style="display: inline; font-style: italic; font: inherit;">2009,</div> Cohen Brothers operated as a privately-owned limited liability company. On <div style="display: inline; font-style: italic; font: inherit;"> December </div><div style="display: inline; font-style: italic; font: inherit;">16,</div> <div style="display: inline; font-style: italic; font: inherit;">2009,</div> Cohen Brothers completed its merger (the “AFN Merger”) with a subsidiary of Alesco Financial Inc. (“AFN”), a publicly traded real estate investment trust.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">As a result of the AFN Merger, AFN contributed substantially all of its assets into Cohen Brothers in exchange for newly issued units of membership interests directly from Cohen Brothers. In addition, AFN received additional Cohen Brothers membership interests directly from its members in exchange for AFN common stock. In accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”), the AFN Merger was accounted for as a reverse acquisition, and Cohen Brothers was deemed to be the accounting acquirer. As a result, all of AFN's assets and liabilities were required to be revalued at fair value as of the acquisition date. The remaining units of membership interests of Cohen Brothers that were <div style="display: inline; font-style: italic; font: inherit;">not</div> held by AFN were included as a component of non-controlling interest in the consolidated balance sheets.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">Subsequent to the AFN Merger, AFN was renamed Cohen & Company Inc. In <div style="display: inline; font-style: italic; font: inherit;"> January 2011, </div>it was renamed again as Institutional Financial Markets, Inc. (“IFMI”) and on <div style="display: inline; font-style: italic; font: inherit;"> September 1, 2017 </div>it was renamed again as Cohen & Company Inc.  Effective <div style="display: inline; font-style: italic; font: inherit;"> January </div><div style="display: inline; font-style: italic; font: inherit;">1,</div> <div style="display: inline; font-style: italic; font: inherit;">2010,</div> the Company ceased to qualify as a REIT.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">On <div style="display: inline; font-style: italic; font: inherit;"> September </div><div style="display: inline; font-style: italic; font: inherit;">1,</div> <div style="display: inline; font-style: italic; font: inherit;">2017,</div> the Company (i) changed its name back from Institutional Financial Markets, Inc. to Cohen & Company Inc. and the Company's trading symbol on the NYSE American Stock Exchange from “IFMI” to “COHN”; (ii) effected a <div style="display: inline; font-style: italic; font: inherit;">1</div> for <div style="display: inline; font-style: italic; font: inherit;">10</div> reverse stock split; and (iii) increased the par value of Common Stock from <div style="display: inline; font-style: italic; font: inherit;">$0.001</div> per share to <div style="display: inline; font-style: italic; font: inherit;">$0.01</div> per share. All share and per share amounts, and exercise and conversion prices for all periods presented reflect the reverse split as if it had occurred as of the beginning of the <div style="display: inline; font-style: italic; font: inherit;">first</div> period presented.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;text-indent:24.5pt;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">The Company</div> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;"></div> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">We are a financial services company specializing in fixed income markets and, more recently, the SPAC markets.  As of <div style="display: inline;"><div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020</div></div>, the Company had <div style="display: inline; font-style: italic; font: inherit;">$2.77</div> billion in assets under management (“AUM”) of which <div style="display: inline; font-style: italic; font: inherit;">$2.06</div> billion, was in collateralized debt obligations (“CDOs”). The remaining portion of AUM is from a diversified mix of Investment Vehicles (as defined herein). </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">In these financial statements, the “Company” refers to Cohen & Company Inc. and its subsidiaries on a consolidated basis.  Cohen & Company, LLC or the “Operating LLC” refers to the main operating subsidiary of the Company. “Cohen Brothers” refers to the pre-AFN Merger Cohen Brothers, LLC and its subsidiaries. “AFN” refers to the pre-merger Alesco Financial Inc. and its subsidiaries. When the term “Cohen & Company Inc.” is used, it is referring to the parent company itself; “JVB Holdings” refers to J.V.B. Financial Holdings, LP; “JVB” refers to J.V.B. Financial Group LLC, a broker dealer subsidiary; “CCFL” refers to Cohen & Company Financial Limited (formerly known as EuroDekania Management LTD), a subsidiary formerly regulated by the Financial Conduct Authority (formerly known as Financial Services Authority) in the United Kingdom; “CCFEL” refers to Cohen & Company Financial (Europe) Limited, a subsidiary regulated by the Central Bank of Ireland in Ireland;  and “EuroDekania” refers to EuroDekania (Cayman) Ltd., a Cayman Islands exempted company that was externally managed by CCFL. </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">The Company's business is organized into the following <div style="display: inline; font-style: italic; font: inherit;">three</div> business segments.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Capital Markets</div>: The Company's Capital Markets business segment consists primarily of fixed income sales, trading, matched book repurchase agreement (“repo”) financing, new issue placements in corporate and securitized products, and advisory services. The Company's fixed income sales and trading group provides trade execution to corporate investors, institutional investors, mortgage originators, and other smaller broker-dealers. The Company specializes in a variety of products, including but <div style="display: inline; font-style: italic; font: inherit;">not</div> limited to: corporate bonds, asset backed securities (“ABS”), mortgage backed securities (“MBS”), residential mortgage backed securities (“RMBS”), CDOs, collateralized loan obligations (“CLOs”), collateralized bond obligations (“CBOs”), collateralized mortgage obligations (“CMOs”), municipal securities, to-be-announced securities (“TBAs”) and other forward agency MBS contracts, Small Business Administration (“SBA”) loans, U.S. government bonds, U.S. government agency securities, brokered deposits and certificates of deposit (“CDs”) for small banks, and hybrid capital of financial institutions including trust preferred securities (“TruPS”), whole loans, residential transition loans ("RTLs"), and other structured financial instruments. The Company also offers execution and brokerage services for equity products. The Company operates its capital markets activities primarily through its subsidiaries: JVB in the United States and CCFEL in Europe.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Asset Management</div>: The Company's Asset Management business segment manages assets within CDOs, managed accounts, joint ventures, and investment funds (collectively referred to as “Investment Vehicles”). A CDO is a form of secured borrowing. The borrowing is secured by different types of fixed income assets such as corporate or mortgage loans or bonds. The borrowing is in the form of a securitization, which means that the lenders are actually investing in notes backed by the assets. In the event of default, the lenders will have recourse only to the assets securing the loan. The Company's Asset Management business segment includes its fee-based asset management operations, which include ongoing base and incentive management fees.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Principal Investing</div>: The Company's Principal Investing business segment is comprised of investments that the Company holds related to its SPAC franchise and other investments the Company has made for the purpose of earning an investment return rather than investments made to support the Company's trading, matched book repo, or other Capital Markets business segment activities.  These investments are included in the Company's other investments, at fair value and investments in equity method affiliates in the Company's consolidated balance sheets. </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">The Company generates its revenue by business segment primarily through the following activities.</div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Capital Markets </div></div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Trading activities of the Company, which include execution and brokerage services, riskless trading activities as well as gains and losses (unrealized and realized) and income and expense earned on securities and derivatives classified as trading;</div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 54pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">• </div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Net interest income on the Company's matched book repo financing activities; and</div> </td> </tr> <tr style="vertical-align: top;"> <td style="width: 54pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">New issue and advisory revenue comprised primarily of (i) new issue revenue associated with originating, arranging, or placing newly created financial instruments; and (ii) revenue from advisory services.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Asset Management </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Asset management fees for the Company's on-going asset management services provided to certain Investment Vehicles, which <div style="display: inline; font-style: italic; font: inherit;"> may </div>include fees both senior and subordinate to the securities in the Investment Vehicle, and incentive management fees earned based on the performance of the various Investment Vehicles.</div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin-bottom:0pt;margin-left:67.5pt;margin-right:0pt;margin-top:0pt;text-align:left;text-indent:-18pt;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;"><div style="display: inline; text-decoration: underline;">Principal Investing </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> </td> <td style="width: 18pt;"> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">•</div> </td> <td> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">Gains and losses (unrealized and realized) and income and expense earned on securities classified as other investments, at fair value.</div> </td> </tr> <tr> <td style="width: 54pt;"> </td> <td style="width: 18pt;">•</td> <td style="font-family: "Times New Roman"; font-size: 10pt;">Income and loss earned on equity method investments.</td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The activities noted above were carried out through the following main operating subsidiaries of the Company as of <div style="display: inline;"><div style="display: inline; font-style: italic; font: inherit;"> December 31, 2020</div></div>. </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; font-family: "Times New Roman"; font-size: 10pt; min-width: 700px;"> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">1.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">Cohen & Company Financial Management, LLC (“CCFM”) is a wholly owned subsidiary of the Operating LLC and acts as asset manager and investment adviser to the Alesco I CDO, and the Alesco III through IX CDOs. Alesco CDOs invest in bank and insurance company TruPS as well as insurance company subordinated debt.  CCFM also manages the SPAC Funds and SPAC Series Funds.  See note <div style="display: inline; font-style: italic; font: inherit;">4.</div></div> </td> </tr> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">2.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">Dekania Capital Management, LLC (“DCM”) is a wholly owned subsidiary of the Operating LLC and acts as asset manager and investment adviser to the Company's Dekania Europe II CDO and Dekania Europe III CDO.  The Dekania Europe II CDO and Dekania Europe III CDO invest primarily in financial institution TruPS and insurance company subordinated debt denominated in Euros.  DCM also manages the U.S. Insurance JV.    </div> </td> </tr> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">3.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">JVB is a wholly owned subsidiary of the Operating LLC. JVB is a securities broker-dealer registered with the Securities and Exchange Commission (“SEC”) and is a member of the Financial Industry Regulatory Authority (“FINRA”), the Securities Industry Protection Corporation (“SIPC”), and the Fixed Income Clearing Corporation (“FICC”).  JVB carries out the Company's Capital Market business segment activities in the U.S.  </div> </td> </tr> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">4.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">CCFL was previously regulated by the United Kingdom Financial Conduct Authority (“FCA”).  CCFL in the past acted as asset manager and investment adviser to the Company's Dekania Europe III CDO. CCFL also carried out certain of the Company's Capital Markets business segment activities in Europe including brokerage, advisory, and new issue services. During <div style="display: inline; font-style: italic; font: inherit;">2020,</div> CCFL reduced its permissions with the FCA and <div style="display: inline; font-style: italic; font: inherit;">no</div> longer is a regulated UK entity. As a result <div style="display: inline; font-style: italic; font: inherit;">no</div> capital requirement is necessary in the United Kingdom. The Company is in the process of dissolving CCFL.  </div> </td> </tr> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">5.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">CCFEL is regulated by Central Bank of Ireland (“CBI”) and performs asset management and capital markets activities in Ireland and the European Union.  In <div style="display: inline; font-style: italic; font: inherit;"> April 2019, </div>CCFEL received authorization from the CBI under the European Union Regulations <div style="display: inline; font-style: italic; font: inherit;">2017</div> to provide investment services in respect of certain financial instruments including transferable securities, money-market instruments, units in collective investment undertakings and various option, futures, swaps, forward rate agreements, and other derivative contracts.  CCFEL also acts as asset manager to certain separate accounts and Investment Vehicles based in Europe. See note <div style="display: inline; font-style: italic; font: inherit;">4.</div></div> </td> </tr> <tr style="vertical-align: top; font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;"><div style="display: inline; font-style: italic; font: inherit;">6.</div></div> </td> <td style="font-family: "Times New Roman"; font-size: 10pt;"> <div style=" font-family: "Times New Roman"; font-size: 10pt; margin: 0pt; text-align: left;">Cohen & Compagnie SAS (formerly Cohen Fréres SAS), the Company's French subsidiary, acts as a credit research adviser to Dekania Capital Management, LLC, and CCFEL in analyzing the creditworthiness of insurance companies and financial institutions in Europe with respect to all assets included in the Dekania Europe CDOs and certain other Investment Vehicles.</div> </td> </tr> <tr style="font-family: "Times New Roman"; font-size: 10pt;"> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"> </td> <td style="width: 18pt; font-family: "Times New Roman"; font-size: 10pt;"><div style="display: inline; font-style: italic; font: inherit;">7.</div></td> <td style="font-family: "Times New Roman"; font-size: 10pt;">SPAC Sponsor Entities:  A series of LLC's set up to pool investor funds and invest in private placements of Company sponsored special purpose acquisition companies ("SPACs").  See note <div style="display: inline; font-style: italic; font: inherit;">4.</div></td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:center;">  </div></div>
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3789000
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5936000
CY2018	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3722000
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11948000
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3734000
CY2018	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2156000
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	41435000
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15463000
CY2018	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-6999000
CY2020	us-gaap	Net Income Loss NetIncomeLoss	14205000
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-2054000
CY2018	us-gaap	Net Income Loss NetIncomeLoss	-2463000
CY2020Q4	us-gaap	Net Income Loss NetIncomeLoss	14751000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	1655000
CY2020Q2	us-gaap	Net Income Loss NetIncomeLoss	901000
CY2020Q1	us-gaap	Net Income Loss NetIncomeLoss	-3102000
CY2019Q4	us-gaap	Net Income Loss NetIncomeLoss	774000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	-1216000
CY2019Q2	us-gaap	Net Income Loss NetIncomeLoss	-410000
CY2019Q1	us-gaap	Net Income Loss NetIncomeLoss	-1202000
CY2020	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	24248000
CY2019	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1519000
CY2018	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-1524000
CY2019	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	-1519000
CY2020	us-gaap	Net Income Loss Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossAttributableToNonredeemableNoncontrollingInterest	24248000
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	39019000
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3039000
CY2018	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-3597000
CY2020	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	42328000
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	4041000
CY2018	us-gaap	Operating Income Loss OperatingIncomeLoss	3659000
CY2020Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	37775000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	6072000
CY2020Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	7926000
CY2020Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-9445000
CY2019Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	4034000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-443000
CY2019Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	518000
CY2019Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-68000
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6531000
CY2019Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7693000
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	1571000
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	1578000
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6063000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7155000
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0543
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P7Y328D
CY2020Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	2442000
CY2019Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	7652000
CY2020Q4	us-gaap	Other Assets OtherAssets	2830000
CY2019Q4	us-gaap	Other Assets OtherAssets	8433000
CY2020Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	255000
CY2019Q4	us-gaap	Other Assets Miscellaneous OtherAssetsMiscellaneous	275000
CY2018	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-80000
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-3000
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	35000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	138000
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2000
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-118000
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2018	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	0
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	138000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-118000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	-38000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	1000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest	103000
CY2018	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-80000
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-3000
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	35000
CY2020	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2019	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2018	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	0
CY2018	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	75000
CY2020	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	19997000
CY2019	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	19653000
CY2018	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	20342000
CY2020Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	166000
CY2019Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	166000
CY2020Q4	us-gaap	Other Investments OtherInvestments	21878000
CY2019Q4	us-gaap	Other Investments OtherInvestments	14315000
CY2020Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	156678000
CY2019Q4	us-gaap	Other Payables To Broker Dealers And Clearing Organizations OtherPayablesToBrokerDealersAndClearingOrganizations	208441000
CY2020Q4	us-gaap	Other Receivables OtherReceivables	3929000
CY2019Q4	us-gaap	Other Receivables OtherReceivables	46625000
CY2018	us-gaap	Partners Capital Account Units Sale Of Units PartnersCapitalAccountUnitsSaleOfUnits	247120
CY2019	us-gaap	Partners Capital Account Units Sale Of Units PartnersCapitalAccountUnitsSaleOfUnits	410820
CY2020	us-gaap	Partners Capital Account Units Sale Of Units PartnersCapitalAccountUnitsSaleOfUnits	402350
CY2018	us-gaap	Partners Capital Account Units Treasury PartnersCapitalAccountUnitsTreasury	750810
CY2019	us-gaap	Partners Capital Account Units Treasury PartnersCapitalAccountUnitsTreasury	318900
CY2020	us-gaap	Partners Capital Account Units Treasury PartnersCapitalAccountUnitsTreasury	1211810
CY2020	us-gaap	Partners Capital Account Units Unitbased Compensation PartnersCapitalAccountUnitsUnitbasedCompensation
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2142000
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	299000
CY2018	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	769000
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	24000
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts
CY2018	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	525000
CY2020	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	27000
CY2019	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	519000
CY2018	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	966000
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	54000
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	128000
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	4352000
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	12675000
CY2018	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments
CY2020	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	62282000
CY2019	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	1927000
CY2018	us-gaap	Payments To Acquire Other Investments PaymentsToAcquireOtherInvestments	26865000
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	217000
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	101000
CY2018	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1002000
CY2020	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	35000
CY2019	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	213000
CY2018	us-gaap	Payments To Minority Shareholders PaymentsToMinorityShareholders	426000
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	60000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	60000000
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	27413098
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	27413098
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	27413098
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	27413098
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	27000
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	27000
CY2020Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	964000
CY2019Q4	us-gaap	Prepaid Expense Current And Noncurrent PrepaidExpenseCurrentAndNoncurrent	796000
CY2020Q4	us-gaap	Prepaid Taxes PrepaidTaxes	0
CY2019Q1	us-gaap	Professional Fees ProfessionalFees	1679000
CY2020	us-gaap	Profit Loss ProfitLoss	38453000
CY2019Q4	us-gaap	Prepaid Taxes PrepaidTaxes	0
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	84000
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	82000
CY2019	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	48000
CY2018	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	8000
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	2166000
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2018	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt
CY2020	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	17500000
CY2019	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2018	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit
CY2020	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	13489000
CY2019	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders	2550000
CY2018	us-gaap	Proceeds From Minority Shareholders ProceedsFromMinorityShareholders
CY2020	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-9163000
CY2019	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	4777000
CY2018	us-gaap	Proceeds From Repayments Of Secured Debt ProceedsFromRepaymentsOfSecuredDebt	-1461000
CY2020	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	54748000
CY2019	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	10114000
CY2018	us-gaap	Proceeds From Sale And Maturity Of Other Investments ProceedsFromSaleAndMaturityOfOtherInvestments	30023000
CY2020	us-gaap	Professional Fees ProfessionalFees	7068000
CY2019	us-gaap	Professional Fees ProfessionalFees	6251000
CY2018	us-gaap	Professional Fees ProfessionalFees	8459000
CY2020Q4	us-gaap	Professional Fees ProfessionalFees	1838000
CY2020Q3	us-gaap	Professional Fees ProfessionalFees	1851000
CY2020Q2	us-gaap	Professional Fees ProfessionalFees	1597000
CY2020Q1	us-gaap	Professional Fees ProfessionalFees	1782000
CY2019Q4	us-gaap	Professional Fees ProfessionalFees	1942000
CY2019Q3	us-gaap	Professional Fees ProfessionalFees	1440000
CY2019Q2	us-gaap	Professional Fees ProfessionalFees	1190000
CY2019	us-gaap	Profit Loss ProfitLoss	-3573000
CY2018	us-gaap	Profit Loss ProfitLoss	-3987000
CY2020Q4	us-gaap	Profit Loss ProfitLoss	43626000
CY2020Q3	us-gaap	Profit Loss ProfitLoss	3343000
CY2020Q2	us-gaap	Profit Loss ProfitLoss	3269000
CY2020Q1	us-gaap	Profit Loss ProfitLoss	-11785000
CY2019Q4	us-gaap	Profit Loss ProfitLoss	1197000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-1918000
CY2019Q2	us-gaap	Profit Loss ProfitLoss	-1028000
CY2019Q1	us-gaap	Profit Loss ProfitLoss	-1824000
CY2020	us-gaap	Property Plant And Equipment Disposals PropertyPlantAndEquipmentDisposals	0
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2119000
CY2019Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1897000
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	799000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	916000
CY2020Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	799000
CY2019Q4	us-gaap	Property Plant And Equipment Net Excluding Capital Leased Assets PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets	916000
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-20341000
CY2020Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	52917000
CY2019Q4	us-gaap	Receivables From Brokers Dealers And Clearing Organizations ReceivablesFromBrokersDealersAndClearingOrganizations	96132000
CY2020Q4	us-gaap	Receivables From Clearing Organizations ReceivablesFromClearingOrganizations	49706000
CY2019Q4	us-gaap	Receivables From Clearing Organizations ReceivablesFromClearingOrganizations	83712000
CY2020	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	17500000
CY2019	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit
CY2018	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-34519000
CY2020	us-gaap	Revenues Revenues	130110000
CY2019	us-gaap	Revenues Revenues	49666000
CY2018	us-gaap	Revenues Revenues	49386000
CY2020Q4	us-gaap	Revenues Revenues	66365000
CY2020Q3	us-gaap	Revenues Revenues	21856000
CY2020Q2	us-gaap	Revenues Revenues	24119000
CY2020Q1	us-gaap	Revenues Revenues	17770000
CY2019Q4	us-gaap	Revenues Revenues	16090000
CY2019Q3	us-gaap	Revenues Revenues	11267000
CY2019Q2	us-gaap	Revenues Revenues	11169000
CY2019Q1	us-gaap	Revenues Revenues	11140000
CY2020	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	47349000
CY2019	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	25228000
CY2018	us-gaap	Salaries Wages And Officers Compensation SalariesWagesAndOfficersCompensation	24762000
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	40
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	5716343000
CY2019Q4	us-gaap	Securities Purchased Under Agreements To Resell SecuritiesPurchasedUnderAgreementsToResell	7500002000
CY2020Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	5713212000
CY2019Q4	us-gaap	Securities Sold Under Agreements To Repurchase SecuritiesSoldUnderAgreementsToRepurchase	7534443000
CY2020Q4	us-gaap	Security Deposit SecurityDeposit	398000
CY2019Q4	us-gaap	Security Deposit SecurityDeposit	656000
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	12553000
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	744000
CY2018	us-gaap	Share Based Compensation ShareBasedCompensation	623000
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	0
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	300000
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19286
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
CY2018	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	319286
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	19286
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	40
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	40
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2018	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2020	us-gaap	Sublease Income SubleaseIncome	318000
CY2019	us-gaap	Sublease Income SubleaseIncome	280000
CY2018	us-gaap	Sublease Income SubleaseIncome	226000
CY2019Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	1489000
CY2020Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	97995000
CY2020Q4	us-gaap	Trading Securities TradingSecurities	242961000
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	7
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue	7
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue
CY2017Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7
CY2018Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	7
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
CY2017	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P328D
CY2018	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P36D
CY2018	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised
CY2018	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	623000
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	744000
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	12553000
CY2018	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	769000
CY2019	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	299000
CY2020	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	2142000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	43909000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	33319000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	101437000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48756000
CY2017Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	48156000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	42438000
CY2017Q3	us-gaap	Stockholders Equity Note Stock Split Conversion Ratio1 StockholdersEquityNoteStockSplitConversionRatio1	10
CY2019Q4	us-gaap	Trading Securities TradingSecurities	307852000
CY2020	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	36113000
CY2019	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2113000
CY2018	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	2126000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2020Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1070377
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1146941
CY2020Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1160144
CY2020Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1146879
CY2019Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1125311
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1143909
CY2020	us-gaap	Use Of Estimates UseOfEstimates	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; font-style: italic;">B. Use of Estimates </div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left; text-indent: 27pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make assumptions and estimates that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</div></div></div></div></div></div></div>
CY2020	us-gaap	Variable Interest Entity Number Of Entities With Unavailability Of Information VariableInterestEntityNumberOfEntitiesWithUnavailabilityOfInformation	2
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5091087
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1681173
CY2018	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1684482
CY2020Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5207263
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5115583
CY2020Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5020453
CY2020Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3940677
CY2019Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	2757194
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1676318
CY2019Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1676318
CY2019Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1665575
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1131085
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1136574
CY2018	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1152073
CY2019Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1143909
CY2019Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1133166

Files In Submission

Name	View Source	Status
0001437749-21-005149-index-headers.html	Edgar Link	pending
0001437749-21-005149-index.html	Edgar Link	pending
0001437749-21-005149.txt	Edgar Link	pending
0001437749-21-005149-xbrl.zip	Edgar Link	pending
cohn-20201231.xml	Edgar Link	completed
cohn-20201231.xsd	Edgar Link	pending
cohn-20201231_cal.xml	Edgar Link	unprocessable
cohn-20201231_def.xml	Edgar Link	unprocessable
cohn-20201231_lab.xml	Edgar Link	unprocessable
cohn-20201231_pre.xml	Edgar Link	unprocessable
cohn20201002_10k.htm	Edgar Link	pending
ex_231440.htm	Edgar Link	pending
ex_231441.htm	Edgar Link	pending
ex_231442.htm	Edgar Link	pending
ex_231443.htm	Edgar Link	pending
ex_231444.htm	Edgar Link	pending
ex_231445.htm	Edgar Link	pending
ex_231616.htm	Edgar Link	pending
ex_231640.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R122.htm	Edgar Link	pending
R123.htm	Edgar Link	pending
R124.htm	Edgar Link	pending
R125.htm	Edgar Link	pending
R126.htm	Edgar Link	pending
R127.htm	Edgar Link	pending
R128.htm	Edgar Link	pending
R129.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R130.htm	Edgar Link	pending
R131.htm	Edgar Link	pending
R132.htm	Edgar Link	pending
R133.htm	Edgar Link	pending
R134.htm	Edgar Link	pending
R135.htm	Edgar Link	pending
R136.htm	Edgar Link	pending
R137.htm	Edgar Link	pending
R138.htm	Edgar Link	pending
R139.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R140.htm	Edgar Link	pending
R141.htm	Edgar Link	pending
R142.htm	Edgar Link	pending
R143.htm	Edgar Link	pending
R144.htm	Edgar Link	pending
R145.htm	Edgar Link	pending
R146.htm	Edgar Link	pending
R147.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$COHN
Cohen & Co Inc. Stock $cohn

2020 Q4 Form 10-K Financial Statement

#000143774921005149 Filed on March 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COHN Cohen & Co Inc. Stock $cohn

2020 Q4 Form 10-K Financial Statement

#000143774921005149 Filed on March 05, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$COHN
Cohen & Co Inc. Stock $cohn